Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Sowa has learned which strategies actually help patients access the treatment they need
2 Pharmacotherapy in obesity and BED: a difficult legacy Pharmacological treatment of obesity has historically faced significant limitations, with many agents demonstrating only moderate efficacy and a high incidence of adverse effects [24, 25]
Semaglutide was approved as Ozempic in 2017 for type 2 diabetes, then at a higher dose as Wegovy in 2021 specifically for obesity, with clinical trials showing around 15% average body weight loss via slowing how quickly the stomach empties
Abbott CA, Vileikyte L, Williamson S, and et al
Cannabis and synaptic reprogramming of the developing brain
doi:10.1002/ijc.28393 155
